Open Forum Infectious Diseases

Papers
(The TQCC of Open Forum Infectious Diseases is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Propensity-Matched Comparison of Timely vs Delayed Antibiotic Therapy in Stenotrophomonas maltophilia Pneumonia208
Avoidance of Emergency Care in the Southeastern United States During the COVID-19 Pandemic172
Activity of Rezafungin Against Echinocandin Non–wild type Candida glabrata Clinical Isolates From a Global Surveillance Program163
Clinical and Public Health Considerations for HPV Vaccination in Midadulthood: A Narrative Review133
Factors Contributing to Pneumococcal, COVID-19, and Influenza Vaccine Uptake Among People Living With HIV in Belgium: A Retrospective Study124
P-1349. Multi-hospital Dissemination of Ampicillin Resistance Associated with a Frame-shift Deletion in pbp4 of Vancomycin-Resistant Enterococcus faecalis (VREfs)110
2419. Increasing Misattribution of Bacteremia as CLABSIs by NHSN Definitions: A Tertiary Care Center Perspective105
308. Injectable Scaffold-based Vaccination For Prevention of Periprosthetic Joint Infection91
Tuberculosis Disease Among Adults Aged 65 Years and Older: Alameda County, California, 2016–201985
Contribution of Biologic Response Modifiers to the Risk of Coccidioidomycosis Severity83
Association of Tecovirimat Therapy With Mpox Symptom Improvement: A Cross-sectional Study—King County, Washington, May–October 202282
Infections Following Gender-Affirming Vaginoplasty: A Single-Center Experience79
83. Infectious Outcomes of CAR T-cell Therapy: Longitudinal Follow Up and Risk Stratification74
Intermittent Versus Daily Trimethoprim/Sulfamethoxazole Regimens for Pneumocystis Pneumonia Prophylaxis: A Systematic Review and Meta-analysis74
734. Efficacy of sulbactam-durlobactam (SUL-DUR) versus colistin in patients with extensively drug-resistant (XDR) and pan-drug resistant (PDR) Acinetobacter baumannii-calcoaceticus complex (AB72
822. Is the Juice Worth the Squeeze: Ophthalmologist Examination for All Hospitalized Patients with Candidemia in a Rural Community67
382. Are errors of omission falsely inflating hospital-onset Clostridioides difficile infection numbers?62
2538. The Impact of Rifampicin on Blood Pressure in Patients Receiving Nifedipine: A Retrospective Study61
1404. Remotely Piloted Aircraft & Quadcopters used in Combating Malaria/Dengue in desert terrain61
2115. Long Term Follow-up and Correlates of Success in Patients on Immune Globulin for Antibody Deficiency57
P-721. Risk Factors Associated with COVID-19 Among Fully Vaccinated Healthcare Workers in Lima, Peru57
328. One-Day Holiday: An Approach to Managing Daptomycin-Induced CK Elevations in OPAT56
1753. Impact of a Pharmacist-Driven Home Hospital Antimicrobial Stewardship Program Pilot within a Large Community Health System55
2678. Prevalence of gonorrhea, chlamydia and syphilis among males living with HIV attending the Antiretroviral Clinic, Hospital Santo Tomás, Panamá, November 2021-March 202254
A Case Report of Melioidotic Prostatic Abscess in a Traveler53
P-1507. In Vitro Activity of Ceftazidime-avibactam against Enterobacterales Isolates Producing Multiple β-lactamases Collected Globally as a Part of the ATLAS Global Surveillance Program from 251
P-291. Whole genome sequencing (WGS) demonstrates high relatedness between carbapenemase-producing Klebsiella pneumoniae isolates cultured from paired rectal swab and blood specimens among hosp49
P-1665. Predictors of Antibiotic Prescription for Upper Respiratory Tract Infections in Cancer Patients49
P-662. Phase III, modified double-blind, randomized, parallel group, active-controlled, multi-center study of Meningococcal quadrivalent ACWY conjugated vaccine in infants from 6 through 23 months of 47
839. Insights into Histoplasmosis in India: A Tertiary Care Centre Experience46
Underdosed and Underappreciated: Why Japanese Community-Acquired Pneumonia Outcomes With Ampicillin-Sulbactam May Not Translate Globally44
849. Histopathology of Cutaneous Invasive Fungal Infections in a Tertiary Cancer Center: Causes, Discordance with Culture, and Histopathologic Determinants of Outcome43
1407. Migration Timing and its Association with Disease Features in a Chagas Disease Cohort in New England42
1957. Increased short-term vaccine effectiveness of BNT162b2 with same-arm vs. cross-arm administration of sequential doses42
665. Modified Superposition in vitro Susceptibility of Aztreonam and Ceftazidime/Avibactam for an NDM-5 Metallo-β-Lactamase-Producing Klebsiella pneumoniae Isolate42
P-735. Acute Bacterial Skin and Skin Structure Infections: A Comparison of Outpatient One-Hour Infusion Oritavancin and Inpatient Vancomycin Use40
P-1193. Epidemiology of Respiratory Syncytial Virus in Young, Hospitalized Children in Jordan: A Prospective Viral Surveillance Study40
855. Distinguishing between drug-susceptible and resistant Neisseria gonorrhoeae from urine samples by image recognition AI.40
912. Impact of Rapid Identification and Stewardship Intervention on Coagulase-negative Staphylococcus Bloodstream Infection (BSI)39
1706. Risk factors for infections caused by extended spectrum beta lactamase (ESBL) producing and Carbapenem-resistant Enterobacterales (CRE) in pediatric critical care settings: A case control study39
Antibiotic Prescribing for Acute Respiratory Illnesses in Persons With HIV Compared With Persons Without HIV38
P-511. Missed Opportunities for Pre-Exposure Prophylaxis Initiation in Hospitalized Persons with Opioid Use Disorder and Infectious Diseases38
1349. Unveiling the Link between COVID-19 and the Gut Microbiome in an Outpatient Cohort with Mild to Moderate Illness37
P-528. Opportunities for PrEP Awareness and Engagement: A Survey among Healthcare-Seeking Cisgender Women in the US37
P-2156. Impact of Metagenomic Next-Generation Sequencing of Plasma Cell-Free DNA on Infectious Diseases Management in Adult and Pediatric Patients37
430. Tumor microbiota and tumor-infiltrating T cells in the tumor microenvironment of colorectal cancer37
Editor’s Note: Development of a Quantitative Antigen Assay to Detect Coccidioidal Chitinase-1 (CTS1) in Human Serum37
178. Assessment of an IOTA (Intravenous to Oral Transition of Antimicrobial Therapy) in Gram Negative Bacteremias at a Community Teaching Hospital37
P-1158. Surgical Outcomes Following Paenibacillus Infant Infectious Hydrocephalus36
1827. Patients with Serious Injection Related Infections (SIRI) have Limited Access to Community-based Infection Prevention and Treatment in Alabama36
829. 5-Flucytosine Longitudinal Antifungal Susceptibility Testing of Cryptococcus neoformans: A Sub-study of the EnACT Trial Testing Oral Amphotericin36
P-1709. Factors Associated with Anti-Methicillin-Resistant Staphylococcus aureus and Anti-Pseudomonas aeruginosa Therapy in Critically Ill Patients with Community-Acquired Pneumonia: A S35
1122. Early Infectious Diseases Consultation and Procalcitonin-Guided Therapy Limits Unnecessary Antibiotic Use in COVID-1935
Has Ghana's Rotavirus Vaccine Switch Met Programmatic Expectations? An Analysis of National Surveillance Data; 2018–202235
Cerebrospinal Fluid Lactate Levels as a Prognostic Indicator in Patients With Cryptococcal Meningitis Who Are HIV Negative: A Retrospective Cohort Study35
P-2095. Ultrasensitive Clostridioides difficile Toxin A/B Assay (in Development) for Higher Diagnostic Accuracy34
P-2184. Antiviral Use among Immigrants with Chronic Hepatitis B (HBV) in Metropolitan-DC33
P-803. A 10-year Retrospective Analysis of Staphylococcus aureus Bacteremia in a Philippine Tertiary Hospital33
377. Impact of VE303, a Defined Bacterial Consortium, on Antimicrobial Resistant Gene Prevalence in Patients with Clostridioides difficile Infection (CDI)33
Systemic Mycoses by Novel Onygenalean Fungal Pathogens Emergomyces spp and Blastomyces percursus in Rwanda33
P-2295. Risk Factors for and Impact of Enteric Gram-negative Infections on Lung Transplant Clinical Outcomes32
From Chaos to Clarity? The Quest for Effective Probiotics in Antibiotic-Associated Diarrhea32
Racial and Sociodemographic Disparities in Hepatitis C Treatment at an Urban Academic Medical Center, 2018–202332
P-2292. The Usual Suspect? Prevalence of Pseudomonas aeruginosa in Diabetic Foot Infections among Kidney Transplant Recipients32
Disseminated TB With IRIS Presenting as a Pancreatic Mass in Newly Diagnosed HIV: A Case Report32
P-1383. Gap in Doxy PEP Prescription for People Living With HIV Compared with PrEP Users in a Primary Care Practice32
2289. Accuracy of the National Early Warning Score 2 (NEWS2) in predicting Mortality and ICU Admission among COVID-19 patients in the Emergency Department of a Tertiary Private Hospital in the Philipp31
1326. Comparison of Positive BioFire® FilmArray® Meningitis Encephalitis (ME) Panels, CSF cultures, CSF Parameters and Inpatient Mortality Among Patients with Bacterial and Fungal Meningitis31
380. Implementation of Pooled Saliva Tests for Universal Screening of Congenital Cytomegalovirus (cCMV) Infection: Lessons Derived Over a 25-Months Period31
P-2248. Modeling the Economic Impact of Different Testing Strategies for Meningitis/Encephalitis in Adult Patients from a US Hospital Perspective30
P-115. Lessons from Establishing a Vaccine Trial Clinic: Insights from the University of Louisville's Center of Excellence for Research in Infectious Diseases30
P-1451. Missed Opportunities for HIV Diagnosis in Mexico City: Unveiling the Gender Gap30
2327. Masking without Mandates: Patient Preferences30
P-1870. Clinical Outcomes of Self-Administered Outpatient Parenteral Antimicrobial Therapy over 12 Years in a Safety Net Hospital29
P-1459. Racial Disparities in Treatment of Community-Acquired Pneumonia in Hospitalized Patients29
P-1844. T cell Subtypes and DNA Methylome Dynamics Predict Infection after Kidney Transplantation29
P-1607. Comparison of In-House Versus Reference Laboratory Antifungal Susceptibility Testing on De-Escalation Rates of Echinocandin Therapy for Candidemia28
P-1523. Evaluation of Standardized Treatment Regimens for Patients with Documented Melioidosis Septicemia at Tertiary Care Hospital in Thailand28
1381. Barriers and Facilitators to Prompt Diagnosis of Tuberculosis in Lima, Peru28
774. Trivia Game for Learning Zoonotic Diseases in Pre-clinical Medical Curriculum28
P-502. Incorporating Behavioral Economics to Educate Adolescents and Young Adults about HIV Pre-Exposure Prophylaxis28
770. HIV Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) knowledge among Medical Students in the Dominican Republic: Are we missing the role of Future Healthcare Provider in PrEP a28
Trimethoprim-Sulfamethoxazole for Staphylococcus Aureus Bacteremia Prophylaxis in Patients on Hemodialysis: A Future Tool for the “Swiss Army Knife” of Antibiotics?28
P-138. Effect of diabetes mellitus on the disease entity and clinical parameters in culture positive melioidosis28
645. " Risk of Disease Severity and Disease Outcomes with Serotype-Specific Dengue Virus among Hospitalized Dengue Patients in a Tertiary Infectious Diseases Hospital: A Five-Year Retrospective Study"28
P-609. Assessment of Parents’ Awareness and Attitudes towards Respiratory Syncytial Virus and its Prevention in the US28
777. Cytomegalovirus: Curriculum-Based Online Education Improves Knowledge, Competence, and Confidence of Physicians27
326. Optimizing DNA Extraction from Pediatric Stool for Diagnosing Tuberculosis and Use in Next Generation Sequencing27
1572. Impact of a Multicenter Fluoroquinolone Stewardship Collaboration on Prescribing Trends over Five Years27
P-193. Risk Factors Associated with Patients Diagnosed with Clostridioides difficile Infection with no Documented Antibiotic Exposures27
1430. Eravacycline associated hypofibrinogenemia during treatment of M.abscessus27
P-1969. Safety, Immunogenicity, and Pharmacokinetics of Repeat Dosing with AZD7442 (Tixagevimab/Cilgavimab): Final Analysis of the ENDURE Phase 2, Dose-Ranging Study in Immunocompromised Participants27
1404. Factors Associated to Decrease in Quality of Life After Mild-Moderate COVID-19: A Cross-Sectional Study.27
509. Role of cell-mediated immune monitoring using Interferon-γ Enzyme-linked Immunosorbent Spot Assay to predict CMV infection within six months after kidney transplantation27
606. Efficacy and Safety of Ceftazidime-Avibactam Comparative Dosage Regimens in Patients with Kidney Injury: A Retrospective Cohort Study27
LB1530. Clinical Benefit of Oral sabizabulin for Hospitalized Adults with CoVID-19 on Supplemental Oxygen26
1244. Inpatient vs. outpatient initiation of Hepatitis C treatment among hospitalized patients who inject drugs: Lessons from a quality improvement project26
1842. Intravenous to Oral Antibiotic Stepdown for Uncomplicated Streptococcal Bacteremia25
1617. Assessment of Bloodstream Infections in Patients with Intrapartum Fever25
2298. Clinical and Demographic Characteristics of COVID-19 in Pediatric Patients in the United States25
1322. Infectious Complications Following Pediatric Lawn Mower Injury: A Case Series25
580. Influenza, SARS-CoV-2, and routine childhood vaccines – trends in vaccine hesitancy in hospitalized children before and during the COVID-19 pandemic25
2810. A synergy test to assess the activity of the Ceftazidime-Avibactam and Aztreonam combination: An experience from a single centre in Malaysia25
“They Just Assume That We’re All Going to Do the Wrong Thing With It. It’s Just Not True”: Stakeholder Perspectives About Peripherally Inserted Central Catheters in People Who Inject Drugs24
913. Incidentally Positive Measles Results with a Commercially Available Multiplex Polymerase Chain Reaction Panel for Exanthems — Tennessee, 2022–202324
236. Treatment of Recurrent Clostridioides difficile Infection With RBX2660 in Patients ≥ 65 Years Old With Underlying Comorbidities24
242. Evaluation of PBP4 promoter variation and clinical outcomes in patients with Enterococcus faecalis bacteremia24
1812. Comparative Activity of Oritavancin and Comparator Agents against Staphylococcus aureus and Streptococcus spp. Causing Skin and Skin Structure Infections in US Medical Centers between 2017–2019 24
751. Decoding a Decade: Temporal Trends of MIC Distribution of Antifungals Against Cryptococcus species From a Reference Laboratory24
1548. Evaluation of rural HIV screening in adults with one or more risk factors24
1405. High risk or unstable substance use may predict OPAT nonadherence among people who use drugs (PWUD) admitted with invasive infections24
1685. Antimicrobial Activity of Aztreonam-Avibactam Against Enterobacterales Causing Infection in United States Hospitals (2019-2021)24
738. Outcomes of Ceftriaxone Versus Antistaphylococcal Penicillins or Cefazolin for Definitive Therapy of Methicillin-susceptible Staphylococcus aureus Bacteremia24
91. Establishing Proof of Concept for a Bivalent RSVpreF Subunit Vaccine for Maternal Immunization24
1048. Biological Determinants of Post-Acute Sequelae of SARS-CoV-224
168. Promising Changes In Antibiotic Utilization Associated With Implementation Of Rapid Multiplex Polymerase Chain Reaction Testing For Bloodstream Infection24
Immune-Based Therapy for Hospitalized Patients With COVID-19 and Risk of Secondary Infections: A Systematic Review and Meta-analysis24
1814. Retrospective Study of Skin and Soft Tissue Actinomycosis in an Urban Pediatric Academic Medical Center24
155. Use of MRSA PCR and Antimicrobial Stewardship Intervention to Limit Anti-MRSA Therapy in Respiratory Tract Infections at a Community Teaching Hospital23
534. Healthcare Resource Utilization and Costs among Patients with COVID-19 in the United States23
Hospitalizations for Unspecified Mycoses in a Large Administrative Data Set and Implications for Fungal Disease Burden Estimates, United States, 2019–202123
Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial23
549. Ensitrelvir for the Treatment of COVID-19 Infection: Evaluation of Taste Disorder and Smell Disorder in the Phase 3 Part of the Phase 2/3 SCORPIO-SR Randomized Controlled Trial23
447. Clinical Features, Risk Factors, and Outcomes of COVID-19 in Immunocompromised Adults Hospitalized with Acute Respiratory Infection23
2717. Beware the bacteria: risk of bacterial infections persists more than 60 days post CAR-T23
603. Comparing assays for Clinical Phage Microbiology in biofilm22
P-1011. Real-World Antifungal Therapy Patterns in US Patients with Invasive Aspergillosis: It’s Complicated22
121. Safety, Tolerability, and Pertussis Immunogenicity Findings From a Randomized, Participant-Blinded, Active-Controlled, Dose-Escalating, Phase 1 Trial of a Tetanus/Diphtheria/Pertussis Booster Vac22
157. Implementation of multidisciplinary diagnostic stewardship for Clostridioides difficile infection during the COVID-19 pandemic at a small Japanese hospital22
266. Cumulative Steroid Dose in Hospitalized Patients and COVID-19 Associated Pulmonary Aspergillosis22
1801. LVAD antimicrobial prophylaxis and infections, a 12-year experience22
1353. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Post-exposure Prophylaxis of COVID-19: Final Analysis of the STORM CHASER Phase 3 Study22
639. Vaccination in Kidney Transplant Candidates22
1228. Evaluation of the Practice of Switching from Intravenous to Oral Antimicrobial Therapy at King Abdulaziz University Hospital22
564. Nocardiosis in Portugal: a single-center experience22
2695. Lung Transplant Recipients With High Risk Cytomegalovirus Mismatch Donors Managed Using A Multimodality Regimen: A Five-Year Study22
P-1776. Impact of Sepsis Recognition Tools and Pharmacy Workflow on Sepsis Management and Outcomes22
120. Safety, Reactogenicity, and Immunogenicity of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60–85 Years in a Randomized, Multicenter, Interventional, First-In-Human, Phase 1/2a Stud22
382. A Hot Topic: the Relationship Between Climate Variability and Vector Specific Trends in Tick-Borne Diseases in New Jersey22
2379. An Urban Detroit Clinic’s Experience in Bivalent COVID-19 Booster Uptake in People Living with HIV22
537. First Week Post-Operative C-Reactive Protein Kinetics Show Different Patterns of Association with Infection Depending on the Type of Surgery22
P-2355. Etiology and symptoms of respiratory tract infections among nursing home residents: Results from multiplex respiratory pathogen testing in the Nursing Home Public Health Response Network, Febr22
972. Bone and Joint Infections : Looking Beyond Gram Positive Bugs, A Case Series from Mumbai, India22
P-125. A Single-Center Descriptive Analysis of Cryptosporidiosis in Immunocompromised Patients21
P-1595. Short Interval Repeat Testing with a Multiplex Pneumonia Panel is Low Yield- A Case for Diagnostic Stewardship21
1084. Comparison of Pediatric SARS-CoV-2 Infections During Spring 2020 and Spring 202121
P-1679. Discrepancies in antibiotic prescribing: revealing inappropriate use patterns21
1110. Why has Utilization of Novel Gram-negative Antibiotics been Sluggish in U.S. Hospitals? A Retrospective Cohort Study to Inform Future Antibiotic Development and Market Entry Rewards21
P-970. Impressions of the Pediatric Infectious Diseases Subspecialty by Pediatric Resident Physicians and Medical Students Following a Peds ID Elective Rotation21
405. Utilization of a novel humble inquiry interview approach in assessing implementation barriers to a Nurse Driven Clostridioides difficile infection (CDI) order set21
1087. COVID-19 in Solid Organ Transplant Recipients: A Single Transplant Center Experience21
228. Increased Incidence of Invasive Haemophilus influenzae Infections in Adults in Central Massachusetts21
1843. Exploring Cisgender Women's HIV Pre-Exposure Prophylaxis (PrEP) Needs and Preferences Across Settings: the Roles of Social-Structural Factors21
Good Results for PJI Caused by Corynebacterium spp. After Algorithmic Surgical Approach and Rifampicin Combination in Implant Retention21
P-1003. Group B Streptococcus Colonization in Pregnant Women and Their Infants: Prevalence of Colonization, Vertical Transmission, and Serotype Dynamics21
Evaluation of the Tuberculosis Infection Care Cascade Among Pregnant Individuals in a Low-Tuberculosis-Burden Setting20
P-1039. Plasma Cathelicidin (LL37) Levels Are not Associated with Candida Gut Colonization in Critically Ill Patients20
620. Pharmacokinetic-Pharmacodynamic Analysis of Oral Vancomycin and Gut Microbiome Changes in Healthy Volunteers: an Exploratory Study20
P-890. Risk Factors Associated with Carbapenem-Resistant Enterobacteria Bacteremia and Mortality in Patients with Acute Leukemia20
P-1340. Genetic Factors Associated with Cefepime and Piperacillin/Tazobactam Resistance in Clinical Extended-Spectrum Beta-Lactamase-Producing Enterobacterales from the Intensive Care Unit20
2160. Emergence of INDEL Mutations in KPC-2: Insights into Ceftazidime-Avibactam and Imipenem-Relebactam Efficacy20
Investigating and Summarizing Information Resources Related to the Clinical Presentation and Diagnosis of Cutaneous Manifestations of Infectious Diseases in Patients With Skin of Color20
P-1754. An Antimicrobial Stewardship Program (ASP) Without Antibiotic Restrictions - Performance Update20
444. Effect of multidisciplinary management of CKD on proteinuria in people with HIV20
1257. Antiretroviral treatment failure in a prospective cohort of Persons Living with HIV in the Philippines20
601. Characterizing Modifiable Risk Factors for Liposomal Amphotericin B (L-AMB) Nephrotoxicity20
2175. Emergence of Dual-Carbapenemase Producing Enterobacterales in Chile After the COVID-19 Pandemic20
P-1976. Incidence and Outcomes of Community-Onset Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections in the Pre- and Post-COVID-19 Pandemic20
P-1873. Telavancin Outcomes in Infections Treated with Outpatient Parenteral Antibiotic Therapy (OPAT)20
P-1139. Surveying Antibiotic Treatment for Pediatric Patients with Suspected Urinary Tract Infections at Madigan Army Medical Center20
124. Activity of Novel b-Lactam/b-Lactamase Inhibitor (BL/BLI) Combinations Against AmpC-Producing Species Collected in United States Hospitals20
Viewpoint on Human Immunodeficiency Virus Medical Care Retention Guidelines in the Coronavirus 2019 Pandemic Era and Beyond: Lessons Learned From Electronic Health Record Screening and Outreach20
2890. Pharmacokinetics, Safety, and Efficacy of Ceftazidime-Avibactam in Neonates and Young Infants with Bacterial Infections: Results from a Phase 2a, 2-part, Open-label, Non-randomized, Multicenter 19
1301. ID Fellows Cup: Developing Confidence Through Content Creation19
2253. Hospitalist Antibiotic Prescribing Patterns by Hour and Weekday19
984. Detection of Mycobacterial Species from Specimens Submitted for Metagenomic Analysis19
P-971. Chogoria Rounds: A Novel Clinical Reasoning Tool for Residents19
2903. Early Experience With Omadacycline For The Treatment Of Diabetic Foot Infections19
407. Prevalence of Post-COVID Sequelae Amongst Fully Vaccinated and Unvaccinated US Hospitalized Veterans19
2843. Risk Factors for Unplanned Healthcare Encounters in Patients Discharged from the Emergency Department with Extended-spectrum β-lactamase Urinary Tract Infections19
P-1424. Patient Experiences at Month 6 after Initiation of Cabotegravir Long-Acting (CAB LA) for PrEP in the First Male Gender Concordant Implementation Science Trial (PILLAR) in the US19
962. Impact of Care Bundle Element Compliance on Clinical Outcomes for Pediatric Patients with Staphylococcus aureus Bacteremia19
2844. Impact of Altered Mental Status on Antibiotic Prescribing in Patients with Pyuria19
1034. Risk Score for the Need of Mechanical Ventilation in Adults Presenting with Encephalitis.19
882. Gender Disparities in Faculty Rank and Mentorship opportunities Within a Sample of US Academic Infectious Disease Divisions19
513. Evaluating the safety of baricitinib versus tocilizumab in hospitalized patients with COVID-1919
166. Impact of Pneumonia Panel Implementation with Stewardship Support on Antibiotic De-escalation in the ICU19
Reactivation of Multidrug-Resistant HSV-1 in a Post–Allogenic Hematopoietic Stem Cell Transplant Patient: Dynamic Detection of the Rare A605V Mutation by Next-Generation Sequencing19
Identifying High-Risk Populations for Sexually Transmitted Infections in Chinese Men Who Have Sex With Men: A Cluster Analysis19
1005. Financial and clinical impact of ceftolozane/tazobactam global recall on the treatment of multi-drug resistant Pseudomonas in a large health system19
1130. Ensovibep antiviral activity in ambulatory patients with COVID-19 is independent of baseline anti-SARS-CoV-2 antibodies and exhibits minimal selective pressure – Results from the placebo-control19
386. Participant Reflections on Their Experiences Participating in Phase 1 and 2 Inpatient Vaccine Trials and Human Challenge Studies19
P-693. RSV Pneumonia Incidence in Solid Organ Transplant Recipients from 2014 to 2023 in an US Collaborative Network18
1970. SARS-CoV-2 T-cell specific responses in allogeneic hematopoietic stem cell transplant recipients after second and third dose of BNT162b2 mRNA vaccine18
Correction to: International Survey Reveals Opportunities to Improve Tuberculous Meningitis Management and the Need for Standardized Guidelines18
Correction to: Diagnostic Dilemmas: A Review of Reported Cases of Human Herpesvirus 6 Encephalitis in Immunocompetent Adults18
1298. High Prescription Rate of Medications with Significant Rifampin Drug Interactions in Patients with Diabetic Foot Osteomyelitis: Should Rifabutin be Included in Clinical Trials for Adjunctive The18
P-450. Burden of Fungal Infection among People Living with HIV (PLHIV): A Nationwide Inpatient Data Analysis (2019-2021)18
P-1063. SCY-247: A Second-generation IV/Oral Triterpenoid Antifungal with Extensive Tissue Distribution and Pharmacokinetics, and Low Drug-Drug Interaction Potential18
P-1617. Clinical and microbiologic outcomes associated with implementation of MALDI-TOF on patients with anerobic, fungal, and non-lactose fermenting specimens18
Outpatient Parenteral Antimicrobial Therapy in a Safety Net Hospital: Opportunities for Improvement18
P-1238. Assessment of Body Weight upon PK of Olorofim in Patients with Invasive Mould Infections18
311. Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) P18
Adenovirus Infections and Disease in Solid Organ Transplant Recipients: Incidence and Outcomes18
P-1386. Developing a Diagnostic Strategy for the Diagnosis of Bacterial Vaginosis: A Shift from Subjective to Objective Approach18
P-1052. Identifying Facility and Specimen Type Associated with Screening-to-Clinical Candida auris Patients in the United States, 2013–202218
P-463. Diversity of KSHV Subtypes in People Living with HIV in a Large Urban Center in Dallas, Texas18
216. Effectiveness of JYNNEOS Vaccination in Preventing Lesion Dissemination Among Individuals with Confirmed Mpox Infection18
Profiles of HBcrAg and pgRNA in Pregnant Women With Chronic HBV Under Different Disease Phases and Antiviral Prophylaxis18
874. Rapid Prediction of Antibiotic Susceptibility in Blood Stream Infections Using Direct Sequencing from Blood Cultures Coupled with Neighbour-Typing Prediction Algorithms.18
567. Performance of IgM and IgG antibodies against Bartonella henselae for diagnosis of Cat Scratch Disease in pediatric patients18
P-177. Contemporary Clinical Characteristics and Outcomes of Leprosy— a Multicenter Network Analysis18
Reply to Heldman et al18
P-1123. Characterization of microbiological isolates in the newborn unit of the San Ignacio university hospital between 2018 and 202218
Household Transmission of Viral Acute Gastroenteritis Among Participants Within an Integrated Health Care Delivery System, 2014–201618
P-71. Combined Orthopaedic and Infectious Disease Periprosthetic Joint Infection Clinic: A Survey Study18
Gaps in Hepatitis A and Hepatitis B Vaccination Among Hepatitis C Antibody–Positive Individuals Experiencing Homelessness18
869. Evaluation of the Impact of Polymicrobial Bloodstream Infections (BSIs) on the Performance of BioFire Blood Culture Identification 2 (BCID2) Multiplex Polymerase Chain Reaction (PCR) Panel18
1023. Suppressed Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide vs. Dolutegravir/Lamivudine: Virologic Failure and Durability17
Estimates of Presumed Population Immunity to SARS-CoV-2 by State in the United States, August 202117
Daptomycin-Resistant Enterococcus Bacteremia Is Associated With Prior Daptomycin Use and Increased Mortality After Liver Transplantation17
A Family at War—Against Tropheryma whipplei : A Case Series17
Coccidioidomycosis-Associated Hospitalizations, United States, 2016–202117
Targeting Chronic Biofilm Infections With Patient-derived Phages: An In Vitro and Ex Vivo Proof-of-concept Study in Patients With Left Ventricular Assist Devices17
Interventions to Improve HIV Care Continuum Outcomes for People With HIV Who Have Incarceration Experience: A Narrative Review17
P-2226. Clinical Validation and Performance of Molecular Syphilis Diagnosis by Loop-Mediated Isothermal Amplification17
P-2354. Neonatal Enterovirus and Parechovirus Infections—National Enterovirus Surveillance System, United States, 2004–202217
P-763. Assessment of the in vitro potency of anti-mycobacterial agents against clinical Mycobacterium avium complex (MAC) pulmonary isolates: implications of intravenous and inhaled amik17
Identifying a Level of Neutralizing Antibody That Correlates With Protection From Clinical Mumps Disease During a 2017 Mumps Outbreak Among Military Service Members17
Implementation of Injectable Cabotegravir/Rilpivirine for Treatment of Human Immunodeficiency Virus in Patients With Substance Use Disorders at a Syringe Exchange Clinic17
Impact of Testing Strategies to Combat a Major Syphilis Outbreak Among Australian Aboriginal and Torres Strait Islander Peoples: A Mathematical Modeling Study17
Characteristics of Streptococcal Toxic Shock Syndrome Caused by Different Beta-hemolytic Streptococci Species: A Single-center Retrospective Study17
Factors Associated With SARS-CoV-2 Attack Rates in Aged Care—A Meta-analysis17
Prevalence of Naturally Occurring HIV-1 Capsid Inhibitor Resistance–Related Mutations in Antiretroviral Therapy–Naïve and –Experienced Individuals in Taiwan17
P-380. Risk Factors and Clinical Outcomes of Breast Surgery Related Surgical Site Infections in Southeast Michigan17
P-800. High prevalence of treatment initiation delays among people diagnosed with multidrug-resistant tuberculosis-Dushanbe, Tajikistan—2019-202117
P-2170. CMV T-cell Immunity Panel (TCIP)-Guided Secondary CMV Prophylaxis Duration in Lung Transplant Recipients17
P-2213. Lung Microbiome Diversity Associated with Hospital Mortality in Intubated Patients Admitted to the ICU17
Challenges in Managing Treatment-Resistant Mpox Complicated by Severe Superinfection17
Navigating Human Immunodeficiency Virus Screening Recommendations for People on Pre-Exposure Prophylaxis and the Need to Update Testing Algorithms17
At-home Testing and Risk Factors for Acquisition of SARS-CoV-2 Infection in a Major US Metropolitan Area17
Younger Children Develop Higher Effector Antibody Responses to SARS-CoV-2 Infection17
Tetanus: A Rare Complication of Black Tar Heroin Use17
Minnesota One Health Antibiotic Stewardship Collaborative: A Reproducible Approach to Facilitate Antimicrobial Stewardship Progress17
Sequential Intravenous-Oral Therapy for Pediatric Streptococcus anginosus Intracranial Infections17
2277. Variability in Changes in Physician Outpatient Antibiotic Prescribing from 2019 to 2021 during the COVID-19 Pandemic in Ontario, Canada17
2943. Hazardous Alcohol Use and Direct-acting Antiviral Therapy Initiation Among People Who Inject Drugs with Current Hepatitis C Infection17
Exploring Natural Immune Responses to Shigella Exposure Using Multiplex Bead Assays on Dried Blood Spots in High-Burden Countries: Protocol From a Multisite Diarrhea Surveillance Study17
Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement16
Emergence of Acquired HIV Drug Resistance Among Individuals Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A National Laboratory-Based Survey 202316
0.41295599937439